This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Becton Dickinson dismissed from allegations in Indian antitrust investigation

By Freny Patel ( April 12, 2022, 07:37 GMT | Insight) -- The US-headquartered medical-technology company Becton Dickinson has been absolved of allegations in a hospital-cartel case by the Indian antitrust authority, which has expanded its investigation to include 11 more hospitals, according to an internal document MLex has seen. What started out as a cartel investigation involving Max Super Specialty Hospital and the US medical-technology company has now been expanded to include three large hospital chains, namely Max Healthcare, Apollo Hospitals, and Fortis Healthcare, on how they fixed the prices of drugs and medical devices.US-headquartered medical-technology company Becton Dickinson has been absolved of allegations of anticompetitive behavior a case involving hospitals by the Indian antitrust authority, which is expanding its investigation to include 11 more hospitals, according to an internal document MLex has seen....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login